040202 - Boston University. Center for Global Health and Development (CGHD)
Document
Treatment out comes of over 1000 patients on second-line, protease inhibitor-based antiretroviral therapy from four public-sector HIV treatment facilities across Johannesburg, South Africa, a document from 2017 PA-00M-SVS